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![Epidermolysis bullosa (EB) is a clinically heterogeneous group of inherited blistering disorders characterized by increased skin fragility, while the dystrophic variant of EB (DEB) is a clinically more severe subtype of EB ([@ref1],[@ref2]). Patients with DEB are at high risk of developing squamous cell carcinoma (SCC), which particularly arise from areas of poorly healing wounds, and lead to metastasis and death ([@ref3]). A 41-year-old female patient with DEB underwent ^18^F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography (^18^F-FDG PET/CT) in the follow-up period. PET/CT showed increased metabolic activity in multifocal cutaneous lesions in both lower extremities. The incisional biopsy performed from the skin of the left lateral lower thigh where one of the increased ^18^F-FDG uptakes was observed revealed invasive SCC (black arrows). There was no other increased pathologic metabolic activity in any part of the skin, lymph nodes or organs](MIRT-28-79-g1){#f1}

![Ten months later, a second PET/CT scan was performed for re-staging purposes due to clinical detection of suspicious inguinal lymph nodes on physical examination. The second PET/CT showed a lymph node with increased FDG uptake in the left inguinal region (SUV~max~: 12.9) as well as additional unexpected lymph nodes in the left supraclavicular region (SUV~max~: 11.0) consistent with local and distant nodal metastasis (black arrows). Due to the multifocal or multiclonal onset of SCC, it is difficult to identify nodal and visceral spread of the tumor ([@ref4]). Despite the high sensitivity of CT and PET/CT to detect subclinical nodal spread, false-positive results are still common. ([@ref5]) By Jennings and Schmults ^18^F-FDG PET is reported to be beneficial to differentiate disease involvement and areas of necrosis and fibrosis. Cho et al. ([@ref6]) have examined 12 SCC patients (nine cases with highrisk SCC) by ^18^F-FDG/PET. The authors have identified lymph node metastases in three cases (25.0%), distant organ involvement in one case (8.3%) and primary lesions in nine cases (83.3%). Mahajan et al. ([@ref7]) reported that ^18^F-FDG PET/CT achieved overall sensitivity and accuracy of 100% and 92%, respectively, in 13 patients with primary SCC. It was emphasized that ^18^F-FDG detected four previously unknown secondary lesions and changed management schedule in three of these. Supportively, Mackie and Avram ([@ref8]) evaluated a 34-year-old woman with EB with soft tissue thickening in the left foot showing an increased ^18^F-FDG uptake, which was confirmed histopathologically as SCC. In conclusion, ^18^F-FDG PET/CT seems to be useful in re-staging and management of follow-up to plan appropriate therapeutic strategy in DEB patients with SCC](MIRT-28-79-g2){#f2}
